Industry Symposia

Friday, February 21, 2014


08:30-10:00
OPTIMIZING ART RESULTS
IBSA Educational program - Hall A
Capsule The IBSA Educational workshop will host distinguished experts discussing optimization of IVF results in light of the large differences that exist among IVF programs in the degree of applications of new technologies as well as applying the most effective stimulation protocol to achieve high success rate in IVF
Chairperson

Luca Gianaroli, Italy
Zi Jiang Chen, China

Tailoring ovarian stimulation for IVF in PCOS patients, while balancing the success and risks
Xuehong Zhang, China
Risk involved in ART: Prevention of OHSS and multiple pregnancies
Stratis Kolibianakis, Greece
Preimplantation genetic diagnosis (PGD) in China
Jie Qiao, China

10:20-11:50 OPTIMIZING ART RESULTS (Cont.)
Chairpersons Stratis Kolibianakis, Greece
Jie Qiao, China
Trophectoderm biopsy and day 3 embryo biopsy: Techniques and pearls
Luca Gianaroli, Italy
Debate: IVM results are as good as IVF
                Accumulated pregnancy rate per egg retrieval versus per embryo transfer
Yes: Ri-Cheng Chian, Canada
No: Nicholas Zech, Austria
Discussion

10:20-11:50
PREDICTION AND PREVENTION OF PRE-ECLAMPSIA
Supported by PerkinElmer - Hall C
Capsule A major development was achieved in recent years in identifying various markers and tools for predicting the disorders which are increased in the maternal circulation before the onset of preeclampsia. However, since the exact pathophysiological mechanism leading to this condition is still poorly understood, can we devise a treatment plan?
Chairpersons Gian Carlo Di Renzo, Italy
Michael Robson, Ireland
Low-dose aspirin improved trophoblastic function in early-onset pre-eclampsia
Fabricio Da Silva Costa, Australia
Pre-eclampsia screening in Asian population 
Angelita Reyes-Teotico, Philippines
Pre-eclampsia screening in clinical practice
Eui-Hyeok Kim, Korea
Should we strive to predict preeclampsia?
Yes: Prediction became a reality, and diagnosis precedes prevention
Terence Lao, Hong Kong

Saturday, February 22, 2014


10:20-11:50
NON-INVASIVE PRENATAL TESTING AND MICRODELETIONS
Supported by Naterna Symposium - Hall C
Capsule
Prenatal diagnosis on cell-free DNA, as a non-invasive method of screening
for chromosomal aneuploidy, is now ready for use mainly in high risk cases. The possibility of detecting point mutation expands the indications.  Sensitivity, specificity and the narrow window for its application remains a concern
Prenatal diagnosis on cell-free DNA, as a non-invasive method of screening for chromosomal aneuploidy, is now ready for use mainly in high risk cases. The possibility of detecting point mutation expands the indications.  Sensitivity, specificity and the narrow window for its application remains a concern
Chairpersons Dan Farine, Canada
Gian Carlo Di Renzo, Italy
Tony Tan, Singapore
 
Is non-invasive prenatal screening ready to replace biochemical screening for Down syndrome?
Tak-Yeung Leung, Hong Kong
 
Integrating NIPT for anueploidies and microdeletions into prenatal care - controversies, considerations and solutions
Susan J. Gross, USA
 
Should we screen maternal carrier state of Fragile X?
Richard Choy, Hong Kong
 
Is there a need of developing a subspecialty in fetal geneticist?
Tak-Yeung Leung, Hong Kong
12:10-13:40
UNDERSTANDING THE SCIENCE AND MANAGEMENT OF POST-OPERATIVE SCAR
Supported by Menarini - Hall C
Chairperson Christopher Chong, Singapore
12:10-12:15

Opening Remarks   
Christopher Chong, Singapore

12:15-12:35 Updates on Asian Scar Management Marie Socouer
L. Medina-Oblepias, Philippines
12:35-13:15 Techniques in Managing and Preventing Abnormal Scarring Post Surgery
Ee Cherk Cheong, Singapore
13:15-13:25 O&G Clinical Experience on Dermatix
Dominic Fuk-Him Li, Hong Kong
13:25-13:40 Q&A and Closing Remarks   
Christopher Chong, Singapore

 

Scientific Information

Scientific Program

Registration & Accommodation

Sponsorship & Exhibition